Carlsmed Q4 Earnings Call Highlights [Yahoo! Finance]
Carlsmed, Inc. (CARL)
Company Research
Source: Yahoo! Finance
Carlsmed reported full-year revenue of $50.5 million (up YoY) and record Q4 revenue of $15.2 million with gross margins in the mid-70s; the company raised $100 million in a July IPO and held $109.9 million in cash and investments despite a 2025 GAAP net loss of $29.6 million Management highlighted strong clinical and reimbursement progress: a published two-year study showed a reduction in reoperation rates with aprevo Lumbar versus stock implants, and CMS granted an NTAP for aprevo Cervical providing up to per inpatient procedure, while manufacturing lead time fell to six business days. Product and commercial momentum continues with the myaprevo Ecosystem and aprevo Cervical launch, first-in-human bilateral posterior and personalized Cora cervical plate procedures (targeting H2 2026 launches), addition of 101 fully trained surgeons, and 2026 revenue guidance of $70–75 million (about growth at the midpoint) with expected mid-70s gross margins. Interested in Carlsmed, Inc.? Here
Show less
Read more
Impact Snapshot
Event Time:
CARL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CARL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CARL alerts
High impacting Carlsmed, Inc. news events
Weekly update
A roundup of the hottest topics
CARL
News
- Carlsmed (CARL) was downgraded by Zacks Research from "hold" to "strong sell".MarketBeat
- Carlsmed, Inc. GAAP EPS of -$0.32 beats by $0.11, revenue of $15.2M beats by $0.34M [Seeking Alpha]Seeking Alpha
- Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]Yahoo! Finance
- Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results GlobeNewswire
- Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference [Yahoo! Finance]Yahoo! Finance
CARL
Earnings
- 2/25/26 - Beat
CARL
Sec Filings
- 3/2/26 - Form 144
- 2/25/26 - Form S-8
- 2/25/26 - Form 10-K
- CARL's page on the SEC website